Heerspink, H J L & DAPA-CKD Trial Committees and Investigators 2022, ' A pre-specified analysis of the Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial on the incidence of abrupt declines in kidney function ', Kidney International, vol. 101, no. 1, pp. 174-184 . https://doi.org/10.1016/j.kint.2021.09.005 Kidney International, 101(1), 174-184. ELSEVIER SCIENCE INC
The New England Journal of Medicine, 367, 14, pp. 1297-309 Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual) Universidade de São Paulo (USP) instacron:USP Roe, M T, Armstrong, P W, Fox, K A A, White, H D, Prabhakaran, D, Goodman, S G, Cornel, J H, Bhatt, D L, Clemmensen, P, Martinez, F, Ardissino, D, Nicolau, J C, Boden, W E, Gurbel, P A, Ruzyllo, W, Dalby, A J, McGuire, D K, Leiva-Pons, J L, Parkhomenko, A, Gottlieb, S, Topacio, G O, Hamm, C, Pavlides, G, Goudev, A R, Oto, A, Tseng, C-D, Merkely, B, Gasparovic, V, Corbalan, R, Cinteză, M, McLendon, R C, Winters, K J, Brown, E B, Lokhnygina, Y, Aylward, P E, Huber, K & Hochman, J S & Ohman, E M 2012, ' Prasugrel versus Clopidogrel for Acute Coronary Syndromes without Revascularization ', New England Journal of Medicine, vol. 367, no. 14, pp. 1297-1309 . https://doi.org/10.1056/NEJMoa1205512 The New England Journal of Medicine, 367, 1297-309